|
|
|
Volumn 295, Issue 3, 2000, Pages 1051-1060
|
|
Anticonvulsant and adverse effects of avermectin analogs in mice are mediated through the γ-aminobutyric acid(A) receptor
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
13 BETA CHLORO 13 DESOXYIVERMECTIN AGLYCONE;
13 EPI AVERMECTIN;
13 EPI O METHOXYMETHYLAVERMECTIN B1A AGLYCONE;
13 EPI O METHOXYMETHYLAVERMECTIN B2A AGLYCONE;
13 O METHOXYMETHYLAVERMECTIN B2A AGLYCONE;
22,23 DIHYDROAVERMECTIN;
22,23 DIHYDROAVERMECTIN A1A;
23 GEM DIFLUOROAVERMECTIN;
23 METHYLAVERMECTIN B2A;
23 OXOAVERMECTIN A2A;
23 OXOAVERMECTIN B2A;
4 DEOXY 4 EPI ACETYLAMINOAVERMECTIN B1A 5 KETOXIME;
4 DEOXY 4 EPI METHYLAMINOAVERMECTIN B1A;
4 O GLUCOSYLAVERMECTIN B1A;
4A O METHOXYETHOXYMETHYL 22,23 DIHYDROAVERMECTIN B1;
5 METHOXYDORAMECTIN;
5 METHOXYEMADECTIN;
ABAMECTIN;
AVERMECTIN;
AVERMECTIN A1A;
AVERMECTIN A2A;
AVERMECTIN B1A AGLYCONE;
AVERMECTIN B2A;
AVERMECTIN B2A AGLYCONE;
AVERMECTIN DERIVATIVE;
DIAZEPAM;
DORAMECTIN;
L 638725;
L 640471;
L 642126;
L 652264;
L 653433;
L 656748;
L 669437;
L 676863;
L 676891;
L 676893;
L 676897;
L 676913;
L 676915;
L 685869;
L 693752;
L 694554;
L 697959;
L 697960;
L 699618;
L 701023;
L 708381;
L 734873;
L 751531;
L 759154;
L 759536;
NEMADECTIN;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL MODEL;
ARTICLE;
BINDING AFFINITY;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG BINDING;
DRUG EFFECT;
DRUG POTENCY;
GABAERGIC TRANSMISSION;
LETHAL DOSE;
MALE;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
SEIZURE;
SPINAL CORD;
TOXICITY TESTING;
ANIMALS;
ANTICONVULSANTS;
CELLS, CULTURED;
CEREBRAL CORTEX;
FEMALE;
IVERMECTIN;
MALE;
MICE;
RATS;
RECEPTORS, GABA-A;
RECEPTORS, GLYCINE;
RECOMBINANT PROTEINS;
XENOPUS;
|
|
EID: 0033712642
PISSN: 00223565
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (113)
|
|
References (26)
|
